Atlas Trials

Study to Investigate AKT Inhibitor GSK690693 in Subjects With Relapsed or Refractory Hematologic Malignancies

Clinical trial NCT00666081 · WITHDRAWN

Trial details

NCT number
NCT00666081
Sponsor
GlaxoSmithKline
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2008-04-01
Primary completion
2009-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.